Taken together, these data demonstrate the orthogonal nature of the proteome data with established genome and transcriptome screens, and highlight the ability of SP3-CTP to yield actionable protein features with potential clinical relevance in the context of ovarian carcinoma. The gene discussed is SP3; the disease is ovarian carcinoma.